Dinarello Charles A 4
4 · BIO-TECHNE Corp · Filed Oct 30, 2017
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Dinarello Charles A
Director
Transactions
- Award
Stock Options (Right to buy)
2017-10-26+3,125→ 3,125 totalExercise: $125.05Exp: 2027-10-26→ Common Stock (3,125 underlying) - Award
Common Stock
2017-10-26+739→ 8,212 total
Holdings
- 4,000
Stock Option (right to buy)
Exercise: $91.78From: 2014-10-30Exp: 2024-10-30→ Common Stock (4,000 underlying) - 5,000
Stock Option (right to buy)
Exercise: $70.35From: 2011-10-27Exp: 2021-10-26→ Common Stock (5,000 underlying) - 5,000
Stock Option (right to buy)
Exercise: $66.90From: 2012-10-25Exp: 2022-10-24→ CommonS tock (5,000 underlying) - 5,000
Stock Option (right to buy)
Exercise: $65.47From: 2008-10-23Exp: 2018-10-22→ Common Stock (5,000 underlying) - 5,000
Stock Option (right to buy)
Exercise: $63.03From: 2009-10-29Exp: 2019-10-28→ Common Stock (5,000 underlying) - 5,000
Stock Option (right to buy)
Exercise: $61.46From: 2010-10-28Exp: 2020-10-27→ Common Stock (5,000 underlying) - 3,985
Stock Options (Right to buy)
Exercise: $101.19From: 2017-10-26Exp: 2026-10-26→ Common Stock (3,985 underlying) - 4,000
Stock Option (right to buy)
Exercise: $87.39From: 2013-10-31Exp: 2023-10-30→ Common Stock (4,000 underlying) - 4,260
Stock Options (Right to buy)
Exercise: $87.34From: 2015-10-29Exp: 2025-10-28→ Common Stock (4,260 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of the one year anniversary of the grant date (10/26/2017) or the date of Bio-Techne 2018 annual meeting of shareholders.